Featured Jobs
|
The Pension Source
|
|
Defined Contribution Account Manager Nova 401(k) Associates
|
|
Relationship Manager - Actuary Daybright Financial
|
|
Senior Counsel – Investment Solutions Great Gray Trust Company
|
|
Plan Admin/Employee Benefits/Office Admin Columbia Benefits, LLC
|
|
Daybright Financial
|
|
BPAS
|
|
Relationship Manager for Defined Benefits Daybright Financial
|
|
Senior Plan Consultant, Defined Benefit DWC - The 401(k) Experts
|
|
Senior Plan Consultant, Defined Benefit DWC - The 401(k) Experts
|
|
Pentegra
|
|
Goldberg, Swedelson & Associates
|
|
401K Safe
|
Free Newsletters
“BenefitsLink continues to be the most valuable resource we have at the firm.”
-- An attorney subscriber
|
|
|
|
Novo, Lilly to Sell Obesity Drugs Directly to Employers
Seeking Alpha; login may be required
Nov. 21, 2025 "Starting from Jan. 1, the pharma giants will offer their obesity drugs Wegovy and Zepbound through Waltz Health, a digital health company focused on helping employers buy affordable medications. Under the offering, employers will procure the injectables by paying upfront, fixed prices without involving rebates and fees, which are usually paid to PBMs as part of traditional drug purchases." MORE >> |
| Please click here to report this link if it is broken (for example, if you see a "404 File Not Found" error message after you click on the linked news item's title). |
| An important word about authorship: BenefitsLink® created this link to the news item, but we are not the news item's author (unless expressly shown above). |